Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Sampling Granules from Fluidized Bed Process – V 2.0

Posted on By

Tablets: SOP for Sampling Granules from Fluidized Bed Process – V 2.0

Standard Operating Procedure for Sampling Granules from Fluidized Bed Process

Department Tablet
SOP No. SOP/TAB/154/2025
Supersedes SOP/TAB/154/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for sampling granules during the fluidized bed granulation process to ensure the granules meet quality standards and specifications before further processing.

2. Scope

This SOP applies to the sampling of granules produced in the fluidized bed process, ensuring uniformity in the granules’ size, moisture content, and other physical properties before proceeding with tablet compression or coating.

3. Responsibilities

  • Quality Control (QC): Responsible for performing the sampling procedure, ensuring that samples are representative and testing them for granule quality parameters.
  • Granulation Operator: Responsible for ensuring that the granulation process is conducted as per the SOP and assisting QC with the sampling of granules.
  • Quality Assurance (QA): Ensures that the sampling process is compliant with the SOP and reviews the results for consistency with the product specifications.

4. Accountability

The QC Manager is accountable for ensuring that the granules are sampled at the correct times and in a manner that ensures accurate and representative

testing. The QA Manager ensures that all steps of the process are followed correctly and approves the test results.

See also  Tablets: SOP for Analytical Method Validation for Tablets - V 2.0

5. Procedure

5.1 Preparation for Sampling

  1. Ensure that the sampling tools, such as clean sampling equipment, gloves, and containers, are prepared and ready for use.
  2. Verify that the fluidized bed system is operating within the defined parameters for granulation, including airflow, temperature, and humidity.
  3. Ensure that the sampling area is clean and appropriately designated for the sampling process.

5.2 Granule Sampling Method

  1. Granules must be sampled from different points within the fluidized bed system to ensure that the sample is representative of the entire batch.
  2. Sample granules from the top, middle, and bottom sections of the fluidized bed. At least three separate points should be sampled to get a homogeneous sample.
  3. If the fluidized bed is equipped with an automatic sampling system, ensure that the system is calibrated and functioning properly. Otherwise, manual sampling should be performed at the specified intervals.

5.3 Sample Size

  1. Sample a minimum of 1-2 kg of granules from each selected point (or as per the batch size and sampling plan).
  2. The total sample size should be representative of the batch and adequate for further testing, such as moisture content, particle size distribution, and uniformity.
See also  Tablets: SOP for Granulation Process for Immediate Release Tablets - V 2.0

5.4 Sampling Interval

  1. Samples should be taken at predefined intervals during the granulation process (e.g., every 30 minutes or as specified by the production batch parameters).
  2. Ensure that samples are taken before any further processing steps, such as drying, to maintain the accuracy of the sample’s characteristics.

5.5 Documentation of Sample Collection

  1. Document the sampling process in the batch record (Annexure-2), including the sample number, sampling point, date, time, and operator details.
  2. Record the number of samples collected and any relevant observations regarding the granulation process.

5.6 Analysis of Granules

  1. Perform the necessary analyses on the samples, including moisture content, particle size distribution, and uniformity testing.
  2. Document the results of the analysis in the batch record, noting any deviations from the predefined specifications.

5.7 Corrective Actions

  1. If the granules do not meet the quality specifications, initiate corrective actions such as adjusting the granulation parameters (e.g., drying time, temperature) or modifying the formulation.
  2. Re-sample and analyze the granules after corrective actions have been implemented to confirm that the issue has been resolved.

5.8 Post-Sampling Actions

  1. After successful sampling and analysis, proceed with the next stage of tablet manufacturing, such as drying or compression.
  2. If issues persist, initiate a thorough review of the granulation process and make any necessary adjustments before continuing production.

See also  Tablets: SOP for Analytical Standards Preparation for Quality Control - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • Moisture Content: The percentage of water present in the granules
  • Particle Size Distribution: The distribution of particle sizes in the granules

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <701> – Granulation and Moisture Testing for Tablets
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Guidelines for Granulation and Tablet Production

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Moisture content outside acceptable range Adjusted drying time and recalibrated equipment John Doe

Annexure-2: Batch Record

Sample Number Moisture Content Particle Size Distribution Uniformity Test Result Action Taken
Sample 1 3.5% Pass Pass Accepted

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated granule sampling criteria Improved process accuracy QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Coating Capsules with Enteric Coatings – V 2.0
Next Post: Creams: SOP for Microbial Challenge Testing of Cream Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version